Last update Jan. 30, 2022
Uultra-long-acting sulfonamide that is used in combination with Pyrimethamine as an antimalarial. Single-dose oral administration, a single dose for treatment and a weekly one for prophylaxis.
At the date of the last update, there was no published data available on its excretion in human milk.
No problems have been observed in infants whose mothers took it. (Kuemmerle 2020).
Use in infants is authorized from the second month (Saito 2018, Roche 2004), so it is unlikely that the amount that passes through the mother’s milk could affect the infant.
Various medical societies and expert consensus consider the use of this medication safe during lactation. (WHO 2010, Chattopadhyay 2007, Peters 2007)
WHO List of Essential Medicines 2002: compatible with lactation in healthy newborns, avoid, if possible, in premature infants and children under one month due to the risk of jaundice. Avoid in glucose-6-phosphate-dehydrogenase deficiency. (WHO-UNICEF 2002)
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Confederación Nacional de Pediatría (CONAPEME) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM